Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 134121 - 134140 out of 485545 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
Czech Republic | (L04AC05) ustekinumab | STELARA | 90MG, 90MG INJ SOL ISP 1X1ML , ISP | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis; Arthritis, Psoriatic; Crohn Disease; Colitis, Ulcerative | Janssen-CilagInternationalN.V.,Beerse |
Czech Republic | (L04AC07) tocilizumab | ROACTEMRA | 20MG/ML, 20MG/ML INF CNC SOL 4X10ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | RocheRegistrationGmbH,Grenzach-Wyhlen |
Czech Republic | (L04AC07) tocilizumab | ROACTEMRA | 20MG/ML, 20MG/ML INF CNC SOL 4X20ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | RocheRegistrationGmbH,Grenzach-Wyhlen |
Czech Republic | (L04AC07) tocilizumab | ROACTEMRA | 20MG/ML, 20MG/ML INF CNC SOL 4X4ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | RocheRegistrationGmbH,Grenzach-Wyhlen |
Czech Republic | (L04AC07) tocilizumab | ROACTEMRA | 162MG, 162MG INJ SOL ISP 4X0,9ML , ISP | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | RocheRegistrationGmbH,Grenzach-Wyhlen |
Czech Republic | (L04AC07) tocilizumab | ROACTEMRA | 162MG, 162MG INJ SOL PEP 4X0,9ML , PEP | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | RocheRegistrationGmbH,Grenzach-Wyhlen |
Czech Republic | (L04AC08) canakinumab | ILARIS | 150MG/ML, 150MG/ML INJ SOL 1X1ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Cryopyrin-Associated Periodic Syndromes; Arthritis, Juvenile Rheumatoid; Arthritis, Gouty | NovartisEuropharmLimited,Dublin |
Czech Republic | (L04AC08) canakinumab | ILARIS | 150MG, 150MG INJ PLV SOL 1 , VIA | Retail price with vat |
$0-0 |
$0-0 |
Cryopyrin-Associated Periodic Syndromes; Arthritis, Juvenile Rheumatoid; Arthritis, Gouty | NovartisEuropharmLimited,Dublin |
Czech Republic | (L04AC02) basiliximab | SIMULECT | 20MG, 20MG INJ/INF PSO LQF 1+1X5ML AMP , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Graft Rejection; Kidney Transplantation | NovartisEuropharmLimited,Dublin |
Czech Republic | (L04AC02) basiliximab | SIMULECT | 20MG, 20MG INJ/INF PLV SOL 1 , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Graft Rejection; Kidney Transplantation | NovartisEuropharmLimited,Dublin |
Czech Republic | (L04AC03) anakinra | KINERET | 100MG/0,67ML, 100MG/0,67ML INJ SOL ISP 7X0,67ML , ISP | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; COVID-19 virus infection | SwedishOrphanBiovitrumAB(publ),Stockholm |
Czech Republic | (L04AC05) ustekinumab | STELARA | 130MG, 130MG INF CNC SOL 1X26ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis; Arthritis, Psoriatic; Crohn Disease; Colitis, Ulcerative | Janssen-CilagInternationalN.V.,Beerse |
Czech Republic | (L04AC05) ustekinumab | STELARA | 45MG, 45MG INJ SOL ISP 1X0,5ML , ISP | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis; Arthritis, Psoriatic; Crohn Disease; Colitis, Ulcerative | Janssen-CilagInternationalN.V.,Beerse |
Czech Republic | (L04AC05) ustekinumab | STELARA | 45MG, 45MG INJ SOL 1X0,5ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis; Arthritis, Psoriatic; Crohn Disease; Colitis, Ulcerative | Janssen-CilagInternationalN.V.,Beerse |
Czech Republic | (L04AC05) ustekinumab | STELARA | 90MG, 90MG INJ SOL ISP 1X1ML , ISP | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis; Arthritis, Psoriatic; Crohn Disease; Colitis, Ulcerative | Janssen-CilagInternationalN.V.,Beerse |
Czech Republic | (L04AC07) tocilizumab | ROACTEMRA | 20MG/ML, 20MG/ML INF CNC SOL 4X10ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | RocheRegistrationGmbH,Grenzach-Wyhlen |
Czech Republic | (L04AC07) tocilizumab | ROACTEMRA | 20MG/ML, 20MG/ML INF CNC SOL 4X20ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | RocheRegistrationGmbH,Grenzach-Wyhlen |
Czech Republic | (L04AC07) tocilizumab | ROACTEMRA | 20MG/ML, 20MG/ML INF CNC SOL 4X4ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | RocheRegistrationGmbH,Grenzach-Wyhlen |
Czech Republic | (L04AC07) tocilizumab | ROACTEMRA | 162MG, 162MG INJ SOL PEP 4X0,9ML , PEP | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | RocheRegistrationGmbH,Grenzach-Wyhlen |
Czech Republic | (L04AC08) canakinumab | ILARIS | 150MG/ML, 150MG/ML INJ SOL 1X1ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Cryopyrin-Associated Periodic Syndromes; Arthritis, Juvenile Rheumatoid; Arthritis, Gouty | NovartisEuropharmLimited,Dublin |